TABLE 2

Effect of 14-day SA treatment on serum and blood parameters

ParameterControlSA-TreatedP Value
Serum creatinine (mmol · l−1)6.8 ± 0.78.6 ± 0.70.09
Serum urea (mmol · l−1)4.7 ± 0.24.9 ± 0.20.64
Serum bilirubin (μmol · l−1)10.1 ± 0.78.0 ± 0.80.07
Serum Na+ (mmol · l−1)140.9 ± 0.4141.1 ± 0.70.72
Serum K+ (mmol · l−1)5.6 ± 0.37.1 ± 0.40.005
Serum CO2 (mmol · l−1)32.0 ± 0.933.3 ± 1.40.45
Hematocrit0.439 ± 0.0090.376 ± 0.011< 0.001
Hemoglobin (g · dl−1)15.0 ± 0.312.6 ± 0.3< 0.001
Mean corpuscular volume (fL)61.7 ± 1.557.1 ± 0.8< 0.001
Erythrocytes (×1012 · l−1)7.1 ± 0.26.6 ± 0.20.08
Leukocytes (×109 · l−1)10.9 ± 1.77.8 ± 2.40.29
Platelets (×109 · l−1)905 ± 55902 ± 1000.81
Serum iron (mol · l−1)31.6 ± 4.738.6 ± 3.10.23
Total iron binding capacity (mol · l−1)80.8 ± 3.079.9 ± 2.50.82
Transferrin saturation (%)39.8 ± 6.849.0 ± 5.50.28
  • Control: n = 7; SA treated: n = 7.